Literature DB >> 12548523

Severe prognosis in a large family with hypokalemic periodic paralysis.

Anna Caciotti1, Amelia Morrone, Raffaele Domenici, Maria Alice Donati, Enrico Zammarchi.   

Abstract

Hypokalemic periodic paralysis (HypoPP) is a channel disorder caused primarily by mutations in the human skeletal muscle alpha1 subunit (CACNA1S) of the dihydropyridine-sensitive calcium channel. Molecular, clinical, and biochemical studies were aimed at establishing genotype/phenotype correlations in a large Italian family affected by a severe form of HypoPP. Whereas patients with HypoPP usually show a normal life span, in this family three male patients died young, one of them from anesthetic complications resembling malignant hyperthermia. Our patients carried the c1583G>A genetic lesion (R528H), which has been associated with a mild phenotype and with incomplete penetrance in women. Surprisingly, the R528H amino acid substitution in the family presented here correlated with an unfavorable prognosis in both male and female patients. We conclude that genetic characterization is an important requirement to alert physicians about the management of similar patients, especially when anesthesia is considered.

Entities:  

Mesh:

Year:  2003        PMID: 12548523     DOI: 10.1002/mus.10298

Source DB:  PubMed          Journal:  Muscle Nerve        ISSN: 0148-639X            Impact factor:   3.217


  10 in total

1.  Novel CACNA1S mutation causes autosomal dominant hypokalemic periodic paralysis in a Chinese family.

Authors:  Qiufen Wang; Mugen Liu; Chunsheng Xu; Zhaohui Tang; Yuhua Liao; Rong Du; Wei Li; Xiaoyan Wu; Xu Wang; Ping Liu; Xianqin Zhang; Jianfang Zhu; Xiang Ren; Tie Ke; Qing Wang; Junguo Yang
Journal:  J Mol Med (Berl)       Date:  2005-02-22       Impact factor: 4.599

Review 2.  Novel etiopathophysiological aspects of thyrotoxic periodic paralysis.

Authors:  Rui M B Maciel; Susan C Lindsey; Magnus R Dias da Silva
Journal:  Nat Rev Endocrinol       Date:  2011-05-10       Impact factor: 43.330

Review 3.  Channelopathies of skeletal muscle excitability.

Authors:  Stephen C Cannon
Journal:  Compr Physiol       Date:  2015-04       Impact factor: 9.090

4.  A Korean family of hypokalemic periodic paralysis with mutation in a voltage-gated calcium channel (R1239G).

Authors:  June Bum Kim; Kyung Yil Lee; Jae Kyun Hur
Journal:  J Korean Med Sci       Date:  2005-02       Impact factor: 2.153

Review 5.  Hypokalemic periodic paralysis: a model for a clinical and research approach to a rare disorder.

Authors:  Bertrand Fontaine; Emmanuel Fournier; Damien Sternberg; Savine Vicart; Nacira Tabti
Journal:  Neurotherapeutics       Date:  2007-04       Impact factor: 7.620

Review 6.  Channelopathies in Cav1.1, Cav1.3, and Cav1.4 voltage-gated L-type Ca2+ channels.

Authors:  Jörg Striessnig; Hanno Jörn Bolz; Alexandra Koschak
Journal:  Pflugers Arch       Date:  2010-03-07       Impact factor: 3.657

7.  PharmGKB summary: very important pharmacogene information for CACNA1S.

Authors:  Katrin Sangkuhl; Robert T Dirksen; Maria L Alvarellos; Russ B Altman; Teri E Klein
Journal:  Pharmacogenet Genomics       Date:  2020-02       Impact factor: 2.000

8.  Hypokalaemia and dysmorphia, is there a link?

Authors:  Stéphane Burtey; Damien Sternberg; Karine Nguyen; Nicole Philip; Yvon Berland; Bertrand Dussol
Journal:  NDT Plus       Date:  2009-02-04

9.  The role of CACNA1S in predisposition to malignant hyperthermia.

Authors:  Danielle Carpenter; Christopher Ringrose; Vincenzo Leo; Andrew Morris; Rachel L Robinson; P Jane Halsall; Philip M Hopkins; Marie-Anne Shaw
Journal:  BMC Med Genet       Date:  2009-10-13       Impact factor: 2.103

10.  An Improved Method for Modeling Voltage-Gated Ion Channels at Atomic Accuracy Applied to Human Cav Channels.

Authors:  Wilnelly Martinez-Ortiz; Timothy J Cardozo
Journal:  Cell Rep       Date:  2018-05-01       Impact factor: 9.423

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.